BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11604999)

  • 1. Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer.
    Kim R; Osaki A; Kojima J; Toge T
    Int J Oncol; 2001 Nov; 19(5):991-6. PubMed ID: 11604999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
    Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
    Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
    Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
    Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer.
    Imoto S; Murakami K; Ikeda H; Fukukita H; Moriyama N
    Ann Nucl Med; 1999 Oct; 13(5):325-9. PubMed ID: 10582802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
    Arcan P; Ibis E; Aras G; Cam R; Küçük NO
    Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology.
    Gentilini O; Trifirò G; Soteldo J; Luini A; Intra M; Galimberti V; Veronesi P; Silva L; Gandini S; Paganelli G; Veronesi U
    Eur J Surg Oncol; 2006 Jun; 32(5):507-10. PubMed ID: 16595168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
    World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
    Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
    J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy in primary breast cancer: radioactive detection and metastatic disease.
    Wada N; Sakemura N; Imoto S; Hasebe T; Ochiai A; Moriyama N
    Eur J Surg Oncol; 2007 Aug; 33(6):691-5. PubMed ID: 17258879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.